Professor Brown was an invited speaker at the recent American Thoracic Society meeting in San Diego, talking about the recent findings his research group has made into how the immune system protects the lungs from protection.
In addition, his clinical PhD students, Dr Jose and Dr Periselneris, presented some of their research data, and Professor Brown attended major symposia on bronchiectasis and pneumonia. These covered a lot of different areas of lung infection, including the increasing problems of antibiotic resistance and how this may be prevented, the use of longterm antibiotics in patients with bronchiectasis (especially azithromycin), and a new scoring system developed in Edinburgh for the severity of disease in patients with bronchiectasis which will help identify those patients requiring particularly intense treatment and will also help with clinical research.
Professor Brown reported that “The conference was very stimulating and provided plenty of ideas for future areas for improving the care of patients with lung infection.”
Recent Articles
- Living with Bronchiectasis Community Days 2026
- Brinsupri™: First medicine licensed for bronchiectasis in the UK
- PET scans offer hope for SSc-ILD patients
- Post-COVID lung microbes stay healthy
- Shedding light on IPF: neutrophils’ hidden role
- Dr Wilson Fox: a 19th century pioneer in pulmonary fibrosis
- New research offers hope for IPF
- Christmas 2025 Newsletter
- A New Year message to our supporters
- A: What Is Pulmonary Fibrosis?
- B: PF versus IPF
- C: Who is at risk from pulmonary fibrosis?
- D: Can pulmonary fibrosis be prevented?
- E: What are the symptoms of pulmonary fibrosis?
- F: How do you diagnose pulmonary fibrosis?



